Patient anxiety and pain levels increase during second cataract surgery

Article

A rise in pain during the second cataract extraction was linked to lower preoperative anxiety and amnestic effects of intravenous sedation, according to a study published in the Journal of Cataract and Refractive Surgery.

A rise in pain during the second cataract extraction was linked to lower preoperative anxiety and amnestic effects of intravenous sedation, according to a study published in the Journal of Cataract and Refractive Surgery.

Dr Roxana Ursea et al., Department of Ophthalmology and Vision, University of Arizona, Tucson, Arizona, USA, conducted a cohort study on 65 patients undergoing bilateral sequential clear corneal extraction. Phacoemulsification was used with topical monitored anaesthesia. Patients excluded from the results were those with baseline eye pain, poor comprehension and complicated cataract extraction. Four brief surveys were completed perioperatively including: the Amsterdam Preoperative Anxiety and Information Scale (APAIS) and the State-Trait Anxiety Scale (STAI). Postoperatively, two visual analogue scale pain surveys were completed with scores between 0 and 10.

Out of the patients, 26 had higher visual analogue scale pain scores during the second cataract operation. The average pain score for the first extraction was 0 on the scale and for the second extraction was 1. Postoperatively, the pain scores were very similar after 1 day. APAIS and STAI anxiety scores lowered between surgeries.

The pain rating recorded in the second cataract extraction was associated with decrease in patient anxiety and amnesic effects, of intravenous sedation.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.